INNOXA LABORATOIRES

What INNOXA LABORATOIRES does

INNOXA LABORATOIRES is a French pharmaceutical manufacturer specializing in ophthalmic medical devices for dry eye, ocular irritation, contact lens care, and periocular hygiene. Founded in 1920 and headquartered in Illkirch-Graffenstaden, the company operates as a wholly-owned subsidiary of BIOSYNEX S.A. following its 2023 acquisition. The brand sells a focused catalog of roughly ten products organized under four sub-brands: Hydrableu (red, tired eye drops with a methylene-blue whitening formula), Hydralose (preservative-free dry eye drops compatible with contact lenses), Hydrallergy (euphrasia and chamomile spray for irritated eyes), and Hydravision (multi-function contact lens solution, hot/cold ocular mask, periocular wipes, and periocular lotion). All products are formulated around floral waters (chamomile, cornflower, melilot, eyebright) combined with trehalose or hyaluronic acid, and are classified as Class I or Class IIb medical devices under the EU Medical Device Regulation.

The business model is wholesale-to-retail OTC consumer healthcare. INNOXA does not sell directly to end consumers; instead, products are distributed through physical pharmacies and parapharmacies in France (with "Acheter en pharmacie" CTAs on the website) and through online pharmacy retailers including Amazon France, Santé Discount, CocoonCenter, and DocMorris. B2B commercial operations, distribution, and customer relationships are handled at the BIOSYNEX group level, with the company's published CGV specifying BIOSYNEX as the contracting party for OTC buyers. Operating geography is restricted to France (including overseas departments) under BIOSYNEX terms, with exports requiring express prior authorization. Pricing is not publicly disclosed, and the revenue model is one-time unit sale of medical devices through the pharmacy and online retail channels.

The customer base is fragmented mass-market French consumers seeking relief from dry eye syndrome, screen-induced eye fatigue, allergies, and contact lens discomfort, with secondary clinical use cases in blepharitis, blepharoconjunctivitis, and pre/post-operative eye care. Brand equity is built on the century-old INNOXA name, with editorial presence in Vogue, Madame Figaro, and Marie France supplementing pharmacy-channel awareness. In 2026, the Hydrableu product was awarded "Meilleur Produit Pharma 2026" in the Eye Care category based on a 100-consumer test scoring above 16/20.

Name

INNOXA LABORATOIRES

Legal name

Laboratoires INNOXA

Website

https://laboratoires-innoxa.com

Company type

Private

Founded year

1920

Operating status

Operating

Headcount range

501–1,000 employees

Short description

INNOXA LABORATOIRES is a French ophthalmic medical device manufacturer (founded 1920, BIOSYNEX subsidiary since 2023) selling eye drops, sprays, contact lens solutions, and periocular hygiene products through French pharmacy retail and online pharmacy channels.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460), Ophthalmic Goods Merchant Wholesalers (42346)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation) (HLAHAJAF)

akta.pro secondary industries

Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE), Eye, Ear & Nasal Care (HLAIADAF)

Keywords

• Ophthalmic medical devices
• Dry eye treatment
• Contact lens solutions
• Periocular hygiene products
• Eye care formulations

Headquarters

HQ city

Illkirch-graffenstaden

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Ophthalmic Medical Device Sales: Sale of branded ophthalmic medical devices including eye drops, sprays, contact lens solutions, and periocular care products through pharmacy retail and online pharmacy distribution channels in France and potentially export markets.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Laboratoires INNOXA manufactures and distributes ophthalmic medical devices including sterile eye drops (Hydrableu, Hydralose), ophthalmic sprays (Hydrallergy), multi-function contact lens solutions, periocular hygiene products (wipes, lotion), and hot/cold eye masks. The products target dry eye syndrome, ocular irritation, redness, fatigue, allergies, and contact lens discomfort, and are distributed primarily through French pharmacies and online pharmacy retailers under the BIOSYNEX group.

Product overview

Laboratoires INNOXA is a manufacturer of ophthalmic medical devices specializing in dry eye treatments and ocular care products. The product portfolio consists of multiple distinct product lines organized by use case: (1) Hydrableu and Hydralose eye drops for treating red, tired, and dry eyes with formulas based on floral waters and trehalose; (2) Hydrallergy spray for allergic eye reactions; (3) Hydravision periocular care line including hot/cold eye masks, cleansing wipes, and lotions for eyelid hygiene; (4) Hydravision multi-purpose contact lens solutions in various sizes; and (5) a cleaning and anti-fog kit for eyeglasses. All products are medical devices (Dispositifs médicaux) compliant with European Community standards.

Differentiator

Problem solved

Functional benefit

Brands

• Hydrableu: Eye drops for red and tired eyes with blue formula, providing hydration, protection and whitening effect
• Hydralose
• Hydrallergy
• Hydravision

Products and services

• Hydrableu – Yeux Rouges et Fatigués Gouttes 10mL Blue sterile ophthalmic solution with methylene blue formulated without preservatives, using floral waters (chamomile, cornflower, melilot, eyebright) and trehalose. Provides moisturizing, protection, and whitening effect for red, tired, dry and irritated eyes. Classified as a medical device compliant with European Community standards.
• Hydralose – Yeux Secs et Irrités Gouttes 10mL Colorless sterile moisturizing, lubricating and soothing ophthalmic solution formulated without preservatives. Contains floral waters and trehalose providing triple action (lubricates, protects, soothes). Suitable for contact lens wearers.
• Hydrallergy – Yeux Rouges et Irrités Spray 10mL Sterile calming, hydrating and refreshing ophthalmic spray with euphrasia (eyebright) and chamomile extracts. Gentle spray usable on open or closed eyes with neutral pH close to tears. For red and irritated eyes caused by allergies.
• Hydravision – Masque Oculaire Chaud/Froid Hot/cold ocular mask to relieve and soothe dry, tired, irritated and swollen eyes. Used in hot or cold application for ocular comfort.
• Hydravision – Lingettes Périoculaires Paupières et Cils x20 Periocular wipes (20 count) for topical treatment of delicate facial areas including eyelids and eyelashes. Gently cleans and soothes sensitive, red, dry or watery eyes. For periocular hygiene including blepharitis management.
• Hydravision – Lotion Périoculaire Paupières et Cils 100mL Periocular lotion (100mL) for eyelid and periocular zone hygiene. Gently cleans and soothes sensitive, red, dry or watery eyes. Classified as Class I medical device under EU Medical Device Regulation.
• Spray 2 en 1 (30ml) + Microfibre + Tournevis universel 2-in-1 cleaning and anti-fog solution kit for eyeglasses and screens. Includes 30mL spray, microfiber cloth and universal screwdriver. Cleans optical lens surfaces and prevents fog formation.
• Hydravision – Solution Multifonction pour Lentilles de Contact Souples 3x360mL + 100mL Sterile multi-function solution (3x360mL + 100mL) for cleaning, hydrating and disinfecting soft contact lenses. Contains hyaluronic acid for improved moistening and increased wearing comfort. Classified as Class IIb medical device under EU Medical Device Regulation.
• Hydravision – Solution Multifonction pour Lentilles de Contact Souples 360mL Multi-function sterile 360mL solution for cleaning, hydrating and disinfecting soft contact lenses (hydrogel and silicone hydrogel). Triple action: hydrates, disinfects and cleans.
• Hydravision – Solution Multifonction pour Lentilles de Contact Souples 100mL Multi-function sterile 100mL solution for cleaning, hydrating and disinfecting soft contact lenses, in travel-friendly format.

Quantifiable outcome

• Products tested and rated above 16/20 by 100 consumers in efficacy, packaging, and texture criteria.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• BIOSYNEX GroupcoreOthersIn 2023, the INNOXA brand was acquired by BIOSYNEX Group. BIOSYNEX recognized an opportunity to create a laboratory brand combining decades of optical and ocular care expertise. Laboratoires Innoxa operates as a subsidiary under the BIOSYNEX umbrella, with BIOSYNEX SA as the parent company (Euronext Growth listed). BIOSYNEX handles B2B sales, distribution, and operations for the Innoxa product line.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• OCuSOFT: US-based company specializing in periocular hygiene products (lid scrubs, warm compress masks) and dry eye treatments. Directly comparable to INNOXA's Hydravision periocular line (wipes, lotion, hot/cold mask).
• Similasan: Swiss ophthalmic company offering natural and homeopathic eye drops (e.g., Similasan Dry Eye, Computer Eye Relief) with botanical ingredients. Comparable to INNOXA's floral water-based natural formulation positioning in OTC eye care.

Broad incumbents

• Alcon: Global leader in eye care with extensive portfolio across surgical, vision care (contact lens solutions like Opti-Free), and dry eye (Systane). Operates across the same OTC pharmacy channel in France and internationally with substantially larger scale and marketing investment.
• Johnson & Johnson Vision: Global vision care company offering contact lens solutions (ACUVUE RevitaLens, Complete) and ocular health products. Directly competes with INNOXA's Hydravision contact lens care line and has stronger consumer brand recognition.
• Allergan Aesthetics / AbbVie: Owner of Refresh Tears and Restasis (cyclosporine) dry eye franchises, plus contact lens care heritage. Competes in the same OTC dry eye category with established pharmacy presence globally.
• Santen Pharmaceutical: Japanese ophthalmic specialty company with European operations (Santen SA in Geneva), offering prescription and OTC dry eye treatments, anti-allergy, and ocular surface products. Directly comparable to INNOXA's therapeutic positioning in ophthalmology.
• Bausch + Lomb: Global ophthalmic company offering contact lens solutions (Biotrue, ReNu), dry eye drops (Artelac, Soothe), and periocular hygiene products. Competes with INNOXA across multiple product categories, particularly contact lens solutions and OTC dry eye treatments.

Direct peers

• Laboratoires Théa: French ophthalmic specialty pharmaceutical company headquartered in Clermont-Ferrand, focused on dry eye, ocular surface disease, and surgical ophthalmology products. Closest direct competitor to INNOXA in the French pharmacy channel with overlapping OTC dry eye and ocular hygiene portfolio.
• URSAPHARM (Hycosan): European ophthalmic company (German-French) specializing in preservative-free eye drops (Hycosan line) and ocular surface care. Closely comparable to INNOXA's preservative-free Hydralose positioning with overlapping European pharmacy distribution.

Regional players

• CooperVision: Global contact lens manufacturer with associated lens care products (Hycosan, contact lens solutions). Comparable to INNOXA's contact lens care line, though primarily a lens manufacturer rather than pure-play care solution brand.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/innoxa

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INNOXA LABORATOIRES